SJMH is committed to reducing spasticity caused by stroke in our community. SJMH offers Intrathecal Baclofen Therapy as a therapeutic option for stroke survivors with severe spasticity.
Stroke is a common cause of disability that can lead to the development of spasticity. Spasticity (or spastic hypertonia) can cause great discomfort and frustration among stroke survivors and their families. Research has reported that stroke survivors with spasticity that have received ITB therapy have shown dramatic improvements in functional motor control, independence, and quality of life.